Protein MG Activators encompass a spectrum of chemical entities that mechanistically foster the augmentation of Protein MG's functional activity within cellular paradigms. Forskolin, by catalyzing the conversion of ATP to cAMP, leads to the activation of protein kinase A (PKA), which can phosphorylate and thus potentiate Protein MG, or its regulatory counterparts, culminating in the amplification of Protein MG's activity. Concurrently, Epigallocatechin gallate (EGCG) operates as a kinase inhibitor, dismantling the negative regulatory barriers upon Protein MG, thereby facilitating an increase in its functional activity. This is complemented by Phorbol 12-myristate 13-acetate (PMA), which activates protein kinase C (PKC) and Ionomycin, a calcium ionophore, both of which enhance the phosphorylation status of Protein MG or its auxiliary proteins, translating to an upsurge in its activity. Further, LY294002 and SB203580, by selectively inhibiting PI3K and p38 MAPK respectively, modulate downstream signaling cascades that culminate in the reduction of inhibitory influences on Protein MG, thus indirectly fostering its activation.
Moreover, U0126's antagonism of MEK1/2, along with Sphingosine-1-phosphate's promotion of sphingolipid signaling, orchestrates a favorable biochemical milieu for Protein MG's activation. Thapsigargin, by sequestering the function of SERCA, engenders a rise in cytosolic calcium levels, which activates calcium-dependent kinases that can phosphorylate and thus enhance Protein MG's activity. Genistein, through tyrosine kinase inhibition, alleviates competitive phosphorylation events, thereby skewing the equilibrium in favor of Protein MG's pathways. Staurosporine, despite its broad-spectrum kinase inhibition, paradoxically can lead to the selective activation of Protein MG pathways by suppressing specific kinases that exert inhibitory control over Protein MG's functional processes. A23187, another calcium ionophore, bolsters intracellular calcium concentrations, further empowering calcium-dependent signaling pathways that are instrumental in the activation of Protein MG. Collectively, these activators orchestrate a symphony of biochemical signals that converge on the enhancement of Protein MG's intrinsic activity without necessitating an upregulation of its expression or direct activation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels, which can enhance the functional activity of "MG" by activating PKA. PKA can then phosphorylate "MG" or associated regulatory proteins, thereby increasing "MG"'s functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that can modulate cellular signaling by inhibiting kinases that negatively regulate "MG", leading to its functional enhancement by reducing inhibitory phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate substrates involved in the activation of "MG" or its signaling complex, resulting in increased "MG" activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent protein kinases that enhance "MG" activity through phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can increase "MG" activity by preventing PI3K from initiating a kinase cascade that results in "MG" inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which may reduce inhibitory phosphorylation of "MG" or its associated proteins, thus enhancing "MG" activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule can activate sphingosine kinase, leading to enhanced "MG" function indirectly by modulating sphingolipid signaling pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels, which can enhance "MG" activity through calcium-dependent signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can enhance "MG" activity by reducing competitive phosphorylation by tyrosine kinases, thus favoring "MG"'s functional pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that, while generally inhibitory, could enhance "MG" activity by selectively inhibiting kinases that negatively regulate "MG". | ||||||